In the US and Europe, your doctor can now write you a prescription for an app – an FDA-cleared software product for depression, ADHD, insomnia or chronic pain, dispensed through a pharmacy or app store. Digital therapeutics are here; the question nobody asks loudly enough is who decided this was medicine, and who stands to benefit most.
Digital therapeutics blur the line between medicine and software, and Australia will face the same regulatory questions soon enough. For the framework Vitroniq uses to evaluate claims like these, see the Digital Health Evaluation Playbook.